
Tabglip-M 2.5/500 Tablet
Marketer
Unilex Lifesciences Pvt Ltd
Salt Composition
Metformin (500mg) + Linagliptin (2.5mg)
Overview Tabglip-M 2.5/500 Tablet
Metformin/glimepiride 2.5/500 mg tablets manage elevated blood glucose in patients with type 2 diabetes. This dual-action medication mitigates serious diabetic complications like nephropathy and retinopathy, potentially lowering cardiovascular event risk. This treatment may be used independently or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a balanced diet and consistent exercise. Dosage is personalized based on individual health status, glycemic control, and concurrent medications. Consuming this medication with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Effective blood sugar management helps prevent future complications. Continued commitment to the prescribed diet and exercise regimen is crucial. Lifestyle choices significantly impact diabetes control. Common adverse effects include nausea, vomiting, diarrhea, stomach upset, headache, nasal congestion, and pharyngitis. Hypoglycemia is a potential risk, particularly when combined with insulin or sulfonylureas; patients should be educated on its recognition and management. This medication is not universally suitable. Prior kidney, liver, or heart disease; pancreatic issues; or significant alcohol consumption should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation. Drug interactions are possible; inform your doctor of all medications taken to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Regular monitoring of kidney function and blood glucose levels will be conducted by your physician throughout treatment.
Uses of Tabglip-M 2.5/500 Tablet
Managing type 2 diabetes
Major Benefits of Tabglip-M 2.5/500 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Tabglip-M 2.5/500 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
Common Side effects of Tabglip-M 2.5/500 Tablet:
- Nausea
- Headache
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
How to use Tabglip-M 2.5/500 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Tabglip-M 2.5/500 Tablet with a meal.
How Tabglip-M 2.5/500 Tablet works:
The tablet Tabglip-M 2.5/500 contains a dual antidiabetic medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Tabglip-M 2.5/500 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Tabglip-M 2.5/500 tablets is contraindicated during pregnancy due to confirmed fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Tabglip-M 2.5/500 tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of Tabglip-M 2.5/500 Tablets is likely inadvisable for individuals with impaired kidney function and should be avoided unless specifically directed by a physician. Medical consultation is recommended.
LiverUNSAFE
Use of Tabglip-M 2.5/500 tablets is likely contraindicated for individuals with hepatic impairment and should be omitted. Medical advice is recommended.
What if you forget to take Tabglip-M 2.5/500 Tablet :
Should you forget a Tabglip-M 2.5/500 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tabglip-M 2.5/500 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
